Blog
Earnings Preview: Essent Group (ESNT) Q2 Earnings Expected to Decline
The market expects Essent Group (ESNT) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus
Analysts Estimate Wendy's (WEN) to Report a Decline in Earnings: What to Look Out for
Wendy's (WEN) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good
Atmus Filtration Technologies (ATMU) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year decline in earnings on higher revenues when Atmus Filtration Technologies (ATMU) reports results for the quarter ended June 2025. While this widely-known
Will New Fortress Energy (NFE) Report Negative Q2 Earnings? What You Should Know
Wall Street expects a year-over-year increase in earnings on higher revenues when New Fortress Energy (NFE) reports results for the quarter ended June 2025. While this widely-known consensus
Will Ur Energy (URG) Report Negative Q2 Earnings? What You Should Know
Ur Energy (URG) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a
Earnings Preview: Gray Media (GTN) Q2 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on lower revenues when Gray Media (GTN) reports results for the quarter ended June 2025. While this widely-known consensus outlook is
Under Armour (UAA) Reports Next Week: Wall Street Expects Earnings Growth
Under Armour (UAA) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a
Okeanis Eco Tankers Corp. (ECO) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Okeanis Eco Tankers Corp. (ECO) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus
Brookfield Renewable (BEP) Reports Q2 Earnings: What Key Metrics Have to Say
Brookfield Renewable Energy Partners (BEP) reported $974 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 17.4%. EPS of -$0.22 for the same period
Will Canopy Growth Corporation (CGC) Report Negative Earnings Next Week? What You Should Know
Canopy Growth Corporation (CGC) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus
Franklin Resources (BEN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Franklin Resources (BEN) reported $2.06 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 2.8%. EPS of $0.49 for the same period compares to $0.60 a year
American Axle & Manufacturing (AXL) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
The market expects American Axle & Manufacturing (AXL) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known
Take a Bite of Apple's Solid Q3 Earnings With These ETFs
Boost Your Portfolio with Our Top ETF Insights
Zacks' exclusive Fund Newsletter delivers actionable information, top news and analysis, as well as top-performing ETFs, straight to your inbox
Best Momentum Stocks to Buy for August 1st
Here are two stocks with buy rank and strong momentum characteristics for investors to consider today, August 1st:
Meta Platforms, Inc. META: This developer of social media platforms has a Zacks
AES Q2 Earnings Outpace Estimates, Revenues Decline Y/Y
The AES Corporation’s AES second-quarter 2025 adjusted earnings of 51 cents per share surpassed the Zacks Consensus Estimate of 39 cents by 30.8%. The bottom line also improved 34.2% from 38 cents
Does CorMedix (CRMD) Have the Potential to Rally 65.64% as Wall Street Analysts Expect?
CorMedix (CRMD) closed the last trading session at $11.67, gaining 0.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Beyond (BYON) Could Rally 57.32%: Here's is How to Trade
Shares of Beyond (BYON) have gained 18.9% over the past four weeks to close the last trading session at $8.95, but there could still be a solid upside left in the stock if short-term price targets
CNB (CCNE) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Shares of CNB Financial (CCNE) have been struggling lately and have lost 5.9% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the
Does Kiniksa Pharmaceuticals International, plc (KNSA) Have the Potential to Rally 35.96% as Wall Street Analysts Expect?
Kiniksa Pharmaceuticals International, plc (KNSA) closed the last trading session at $30.26, gaining 8.5% over the past four weeks, but there could be plenty of upside left in the stock if
After Golden Cross, Invesco (IVZ)'s Technical Outlook is Bright
Invesco Ltd. (IVZ) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, IVZ's 50-day simple moving average broke out above its 200-day
Wall Street Analysts See a 44.47% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
Omnicell (OMCL) closed the last trading session at $31.01, gaining 3.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Bears are Losing Control Over Futu Holdings (FUTU), Here's Why It's a 'Buy' Now
A downtrend has been apparent in Futu Holdings Limited Sponsored ADR (FUTU) lately. While the stock has lost 7.9% over the past week, it could witness a trend reversal as a hammer chart pattern was
Wall Street Analysts Believe Rapt Therapeutics (RAPT) Could Rally 122.22%: Here's is How to Trade
Shares of Rapt Therapeutics (RAPT) have gained 34.2% over the past four weeks to close the last trading session at $10.8, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Predict a 26.72% Upside in Gentherm (THRM): Here's What You Should Know
Gentherm (THRM) closed the last trading session at $32.04, gaining 4.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Camden's Q2 FFO & Revenues Beat Estimates, '25 View Raised
Camden Property Trust CPT reported second-quarter 2025 core funds from operations (FFO) per share of $1.70, surpassing the Zacks Consensus Estimate of $1.69. However, the figure marginally declined


